“In February 2021, the results of the STEP 1 experiment were released, showcasing the efficacy of semaglutide injections in promoting weight loss. On average, participants who received semaglutide lost approximately 15% of their body weight, a significant difference compared to those who received a placebo, who only experienced a 2.4% reduction. Furthermore, over one-third of patients who received semaglutide saw a loss of more than 20% of their body weight. In addition to weight loss, numerous individuals reported improvements in their blood sugar levels, quality of life, and reduction in risk factors for heart disease.”